Dr. Martens plc (LON:DOCS - Get Free Report) insider Giles Wilson bought 189 shares of the firm's stock in a transaction on Wednesday, June 11th. The stock was bought at an average price of GBX 79 ($1.08) per share, with a total value of £149.31 ($203.28).
Giles Wilson also recently made the following trade(s):
- On Friday, April 11th, Giles Wilson acquired 297 shares of Dr. Martens stock. The stock was acquired at an average cost of GBX 51 ($0.69) per share, with a total value of £151.47 ($206.22).
- On Tuesday, March 25th, Giles Wilson purchased 32,640 shares of Dr. Martens stock. The shares were acquired at an average price of GBX 54 ($0.74) per share, with a total value of £17,625.60 ($23,996.73).
Dr. Martens Price Performance
Shares of Dr. Martens stock traded down GBX 0.70 ($0.01) on Friday, hitting GBX 75.80 ($1.03). The company had a trading volume of 1,895,532 shares, compared to its average volume of 2,274,796. Dr. Martens plc has a 52 week low of GBX 43.02 ($0.59) and a 52 week high of GBX 85.10 ($1.16). The company has a debt-to-equity ratio of 127.27, a current ratio of 2.85 and a quick ratio of 1.13. The company has a market cap of £735.84 million, a PE ratio of 10.75, a PEG ratio of 6.40 and a beta of 0.11. The business has a 50-day simple moving average of GBX 57.68 and a 200-day simple moving average of GBX 63.41.
Dr. Martens (LON:DOCS - Get Free Report) last issued its quarterly earnings results on Thursday, June 5th. The company reported GBX 2.40 ($0.03) earnings per share (EPS) for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. Research analysts expect that Dr. Martens plc will post 2.5809394 EPS for the current fiscal year.
Dr. Martens Cuts Dividend
The firm also recently disclosed a dividend, which was paid on Tuesday, April 8th. Stockholders of record on Thursday, March 6th were given a dividend of GBX 0.85 ($0.01) per share. The ex-dividend date of this dividend was Thursday, March 6th. This represents a dividend yield of 1.47%. Dr. Martens's dividend payout ratio (DPR) is 42.53%.
Analyst Ratings Changes
Separately, Royal Bank of Canada reduced their price objective on shares of Dr. Martens from GBX 7,000 ($95.30) to GBX 6,000 ($81.69) and set a "sector perform" rating for the company in a report on Monday, May 19th.
Get Our Latest Report on DOCS
Dr. Martens Company Profile
(
Get Free Report)
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Read More
Before you consider Dr. Martens, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.
While Dr. Martens currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
